AMY WELLS: Open Payments
NPI 1467480574 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,377 in 155 payments from 21 companies in 2025. Trend: 2023 $2,935 · 2024 $3,439 · 2025 $3,377
Food & beverage: $3,122Education: $255
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $606 |
| Janssen Biotech, Inc. | 21 | $537 |
| Amgen Inc. | 6 | $221 |
| Regeneron Healthcare Solutions, Inc. | 6 | $205 |
| UCB, Inc. | 7 | $198 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 7 | $178 |
| Arcutis Biotherapeutics, Inc. | 14 | $176 |
| GENZYME CORPORATION | 8 | $173 |
| Botanix SB Inc | 11 | $149 |
| LEO Pharma Inc. | 9 | $148 |
Products named: TREMFYA, SKYRIZI, DUPIXENT, OTEZLA, Bimzelx, Zoryve, RINVOQ, SOFDRA.
Industry payments across FL — which companies pay providers there.
